These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36891710)

  • 1. [Regulatory mechanism and potential value of circular RNA in nonalcoholic fatty liver disease progression].
    Xie Q; Wang LL; Wang L; Yao DF; Yao M
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1270-1275. PubMed ID: 36891710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription.
    Huang F; Liu H; Lei Z; Li Z; Zhang T; Yang M; Zhou K; Sun C
    J Cell Physiol; 2020 Dec; 235(12):9819-9833. PubMed ID: 32413192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Zeng Q; Liu CH; Wu D; Jiang W; Zhang N; Tang H
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis.
    Li J; Qi J; Tang Y; Liu H; Zhou K; Dai Z; Yuan L; Sun C
    J Nanobiotechnology; 2021 Nov; 19(1):363. PubMed ID: 34789275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data.
    Yuan X; Diao J; Du A; Wen S; Zhou L; Pan Y
    J Transl Med; 2020 Dec; 18(1):476. PubMed ID: 33308253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease.
    Matboli M; Gadallah SH; Rashed WM; Hasanin AH; Essawy N; Ghanem HM; Eissa S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.
    Guo J; Zhou Y; Cheng Y; Fang W; Hu G; Wei J; Lin Y; Man Y; Guo L; Sun M; Cui Q; Li J
    Cell Physiol Biochem; 2018; 45(4):1487-1505. PubMed ID: 29466788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance.
    Zeng Q; Liu CH; Ampuero J; Wu D; Jiang W; Zhou L; Li H; Bai L; Romero-Gómez M; Tang H
    RNA Biol; 2024 Jan; 21(1):1-15. PubMed ID: 38113132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
    Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
    Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications.
    Yepmo M; Potier JB; Pinget M; Grabarz A; Bouzakri K; Dumond Bourie A
    Front Endocrinol (Lausanne); 2022; 13():1035159. PubMed ID: 36407314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
    Cui J; Wang Y; Xue H
    Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs.
    Mukherjee AG; Wanjari UR; Gopalakrishnan AV; Katturajan R; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Renu K; Dey A; Vellingiri B; Prince SE
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3.
    Jin SS; Lin XF; Zheng JZ; Wang Q; Guan HQ
    Eur Cytokine Netw; 2019 Sep; 30(3):98-106. PubMed ID: 31957704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
    Fang Z; Dou G; Wang L
    Int J Biol Sci; 2021; 17(7):1851-1863. PubMed ID: 33994867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c/SIK2/PI3K/Akt axis.
    Li Y; Cen CQ; Liu B; Zhou L; Huang XM; Liu GY
    Kaohsiung J Med Sci; 2022 Sep; 38(9):869-878. PubMed ID: 35791807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A micro-RNA expression signature for human NAFLD progression.
    Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
    J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling.
    Guo XY; Sun F; Chen JN; Wang YQ; Pan Q; Fan JG
    World J Gastroenterol; 2018 Jan; 24(3):323-337. PubMed ID: 29391755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNA-PI4KB Induces Hepatic Lipid Deposition in Non-Alcoholic Fatty Liver Disease by Transporting miRNA-122 to Extra-Hepatocytes.
    Liu CH; Jiang W; Zeng Q; Wu D; Li H; Zhou L; Bai L; Tang H
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease.
    Zaiou M
    World J Gastroenterol; 2022 Sep; 28(35):5111-5128. PubMed ID: 36188722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.